According to CEO Philip O’Neill of Kyoto-based Parkdale Group, when you factor in pharma, medical devices and other healthcare technology, the Japanese healthcare market is probably the world’s second or third largest.  “Japan’s spend on prescription and nonprescription pharma is something like US$110 billion,” he notes, “and medical devices are probably around US$30 billion. This … Continue reading Curative Powers